| Added by | mollevi |
|---|---|
| Last modified by | André Pèlegrin |
| Group name | EquipeAP |
| Item Type | Journal Article |
| Title | [Doses to organs at risk for conformational and stereotactic radiotherapy: Bladder] |
| Creator | Duverge et al. |
| Author | L. Duverge |
| Author | J. Castelli |
| Author | T. Lizee |
| Author | R. de Crevoisier |
| Author | D. Azria |
| Abstract | Bladder dose constraints in case of conformational radiotherapy/intensity-modulated radiotherapy and stereotactic radiotherapy are reported from the literature, in particular from the French radiotherapy society RECORAD recommendations, according to the treated pelvic tumor sites. The dose-volume effect on urinary toxicity is not clearly demonstrated, making difficult to establish absolute dose constraints for the bladder. In case of high-dose prostate cancer radiotherapy, the bladder dose constraints are: V60Gy<50% and maximum dose<80Gy for standard fractionation and V60Gy<5%, V48Gy<25% and V41Gy<50% for moderate hypofractionation (20 fractions of 3Gy). In case of prostate stereotactic radiotherapy (five fractions of 7.25Gy), the most frequent dose constraints in the literature are V37Gy<10cm3 and V18Gy<40%. In case of conformational radiotherapy of cervix cancer, postoperative endometrium, anal canal and rectum, the recommendations are V40Gy<40% and D2% lower than the prescribed dose. |
| Publication | Cancer Radiother |
| Date | Sep 04 2017 |
| Journal Abbr | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique |
| DOI | 10.1016/j.canrad.2017.07.038 |
| ISSN | 1769-6658 (Electronic) 1278-3218 (Linking) |
| Tags | clinique hors équipe, Contraintes de dose, didactique, Dose constraints, Female, Humans, IMRT, nonvisible, Organs at Risk, Pelvic Neoplasms, Practice Guidelines as Topic, Radiosurgery, Radiothérapie, Radiothérapie conformationnelle par modulation d'intensité, Radiotherapy, Radiotherapy, Conformal, review, Urinary Bladder, Vessie |
| Date Added | 2018/07/20 - 10:01:50 |
| Date Modified | 2019/12/11 - 18:27:08 |
| Notes and Attachments | (Note) (Note) 28882511 (Attachment) |
Institut de Recherche en Cancérologie de
